Complications of mechanical ventilation - The CDC's new surveillance paradigm

New England Journal of Medicine

Volumn 368, Issue 16, 2013, Pages 1472-1475

  Klompas, Michael ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADVERSE OUTCOME; ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; CLINICAL PRACTICE; DISEASE SEVERITY; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; PATIENT ASSESSMENT; PATIENT CARE; PNEUMONIA; PRIORITY JOURNAL; SHORT SURVEY; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84876335299     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1300633     Document Type: Article

References (5)

1. Centers for Disease Control and Prevention. Surveillance for ventilator-associated events (http://www.cdc.gov/nhsn/acute-care-hospital/vae/ index.html).
2. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN) report, data summary for 2010, device-associated module. Am J Infect Control 2011;39:798-816.
3. Klompas M, Khan Y, Kleinman K, et al. Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS One 2011;6(3):e18062.
4. Hayashi Y, Morisawa K, Klompas M, et al. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis 2013;56:471-7.
5. Klompas M, Magill S, Robicsek A, et al. Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med 2012;40:3154-61.